EI
BLUE

Ellevest Inc’s bluebird bio BLUE Stock Holding History

Ellevest Inc’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-24
Closed -$1.53K – 532
2023
Q1 		$1.53K Sell
24
-14
-37% -$1.6K ﹤0.01% 1506
2022
Q4 		$5.32K Sell
38
-1
-3% -$141 ﹤0.01% 1171
2022
Q3 		$5K Buy
39
+14
+56% +$1.58K ﹤0.01% 1160
2022
Q2 		$2K Buy
+25
New +$1.94K ﹤0.01% 1139
2020
Q3 		– Sell
-1
Closed -$1K – 1144
2020
Q2 		$1K Sell
1
-8
-89% -$6.03K ﹤0.01% 962
2020
Q1 		$5K Buy
9
+8
+800% +$7.8K ﹤0.01% 637
2019
Q4 		$2K Buy
+1
New +$1.09K ﹤0.01% 670

Other funds holding BLUE

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Ellevest Inc's BLUE Position: Q2 2023 in Review

Ellevest Inc sold out of bluebird bio (BLUE) in Q2 2023, closing a stake of 24 shares — an estimated $1.53K sold.

Ellevest Inc first reported a position in BLUE in Q4 2019 and held it in 7 quarters. The position peaked at $5.32K in Q4 2022. 175 funds tracked by Wall St. Rank hold BLUE as of Q2 2023.

  • Ellevest Inc reported no remaining bluebird bio position as of Q2 2023 after selling out during the quarter.
  • Ellevest Inc sold 24 bluebird bio shares in Q2 2023, an estimated $1.53K.
  • Ellevest Inc first reported a position in bluebird bio in Q4 2019 and held it in 7 quarters.
  • Ellevest Inc's bluebird bio position peaked at $5.32K in Q4 2022.
  • 175 funds tracked by Wall St. Rank held bluebird bio as of Q2 2023.

Based on Ellevest Inc's 13F filing for Q2 2023, filed 9 Aug 2023.